FI814172L - Maennisko-proinsulin och daermed analoga foereningar och framstaellningsmetod genom mikrobiell polypeptid-expression och oeverfoering daerav i maennisko-insulin - Google Patents

Maennisko-proinsulin och daermed analoga foereningar och framstaellningsmetod genom mikrobiell polypeptid-expression och oeverfoering daerav i maennisko-insulin

Info

Publication number
FI814172L
FI814172L FI814172A FI814172A FI814172L FI 814172 L FI814172 L FI 814172L FI 814172 A FI814172 A FI 814172A FI 814172 A FI814172 A FI 814172A FI 814172 L FI814172 L FI 814172L
Authority
FI
Finland
Prior art keywords
och
maennisko
microbiell
framstaellningsmetod
daermed
Prior art date
Application number
FI814172A
Other languages
English (en)
Finnish (fi)
Inventor
David V Goeddel
Keiichi Itakura
Dennis G Kleid
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of FI814172L publication Critical patent/FI814172L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
FI814172A 1981-01-02 1981-12-28 Maennisko-proinsulin och daermed analoga foereningar och framstaellningsmetod genom mikrobiell polypeptid-expression och oeverfoering daerav i maennisko-insulin FI814172L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22204481A 1981-01-02 1981-01-02

Publications (1)

Publication Number Publication Date
FI814172L true FI814172L (fi) 1982-07-03

Family

ID=22830549

Family Applications (1)

Application Number Title Priority Date Filing Date
FI814172A FI814172L (fi) 1981-01-02 1981-12-28 Maennisko-proinsulin och daermed analoga foereningar och framstaellningsmetod genom mikrobiell polypeptid-expression och oeverfoering daerav i maennisko-insulin

Country Status (12)

Country Link
EP (1) EP0055945A3 (fr)
JP (1) JPS57163352A (fr)
KR (1) KR830007828A (fr)
AU (1) AU7914581A (fr)
DK (1) DK582481A (fr)
ES (1) ES8401777A1 (fr)
FI (1) FI814172L (fr)
GR (1) GR78327B (fr)
IL (1) IL64634A (fr)
NZ (1) NZ199391A (fr)
PH (1) PH20660A (fr)
ZA (1) ZA818953B (fr)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ199722A (en) * 1981-02-25 1985-12-13 Genentech Inc Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain
CA1204682A (fr) * 1981-06-19 1986-05-20 Saran A. Narang Adapteurs, synthese et clonage des genes proinsuliniques
US4532207A (en) * 1982-03-19 1985-07-30 G. D. Searle & Co. Process for the preparation of polypeptides utilizing a charged amino acid polymer and exopeptidase
JPS58183659A (ja) * 1982-03-31 1983-10-26 ジェネテイックス、インスチチュ−ト、インコ−ポレ−テッド 修飾プロインシュリン前駆体、これを暗号化するｄｎａ配列およびそれらの産生方法
GB8308235D0 (en) * 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
IL71991A (en) 1983-06-06 1994-05-30 Genentech Inc Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes
US4758512A (en) * 1984-03-06 1988-07-19 President And Fellows Of Harvard College Hosts and methods for producing recombinant products in high yields
DK58285D0 (da) * 1984-05-30 1985-02-08 Novo Industri As Peptider samt fremstilling og anvendelse deraf
DK129385A (da) * 1985-03-22 1986-09-23 Novo Industri As Peptider og fremstilling deraf
DK437786D0 (da) * 1986-09-12 1986-09-12 Nordisk Gentofte Insulinprecursorer
DE3716722A1 (de) * 1987-05-19 1988-12-01 Hoechst Ag Gentechnologisches verfahren zur herstellung von angiogeninen
US6875589B1 (en) 1988-06-23 2005-04-05 Hoechst Aktiengesellschaft Mini-proinsulin, its preparation and use
US5716927A (en) * 1988-12-23 1998-02-10 Novo Nordisk A/S Insulin analogs having a modified B-chain
US5514646A (en) * 1989-02-09 1996-05-07 Chance; Ronald E. Insulin analogs modified at position 29 of the B chain
CA2051375C (fr) * 1989-05-04 2000-09-12 Dennis J. Henner Procede et compositions pour l'isolement de la relaxine humaine
US5126249A (en) * 1989-05-09 1992-06-30 Eli Lilly And Company Enzymatic removal of a protein amino-terminal sequence
DE59305396D1 (de) 1992-12-02 1997-03-20 Hoechst Ag Verfahren zur Gewinnung von Proinsulin mit korrekt verbundenen Cystinbrücken
US6001604A (en) * 1993-12-29 1999-12-14 Bio-Technology General Corp. Refolding of proinsulins without addition of reducing agents
DE4405179A1 (de) * 1994-02-18 1995-08-24 Hoechst Ag Verfahren zur Gewinnung von Insulin mit korrekt verbundenen Cystinbrücken
KR0150565B1 (ko) * 1995-02-15 1998-08-17 김정재 유전자 조환에 의한 사람 인슐린 전구체의 제조 및 이를 이용한 인슐린의 제조방법
US6068993A (en) * 1997-07-02 2000-05-30 Biobras Sa Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin
DE19735711C2 (de) * 1997-08-18 2001-04-26 Aventis Pharma Gmbh Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken
KR100253916B1 (ko) * 1997-12-29 2000-05-01 김충환 사람 인슐린 전구체의 제조방법
JP4472870B2 (ja) 1998-03-31 2010-06-02 トンファ ガンテク バイオテクノロジー リミティド 分子内シャペロン様配列を含有するキメラタンパク質およびインスリン製造へのその適用
DE19838097A1 (de) 1998-08-24 2000-03-02 Hoechst Marion Roussel De Gmbh Verfahren zur chromatographischen Reinigung von Insulinen
JP3406244B2 (ja) * 1999-04-30 2003-05-12 伊藤ハム株式会社 新規な融合蛋白質からの組み換えインスリンの製造方法
US6777207B2 (en) 1999-12-29 2004-08-17 Novo Nordisk A/S Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast
US6521738B2 (en) 1999-12-29 2003-02-18 Novo Nordisk A/S Method for making insulin precursors and insulin precursor analogs
ATE474930T1 (de) 1999-12-29 2010-08-15 Novo Nordisk As Verfahren zur herstellung von insulinvorläufern und analogen von insulinvorläufern mit verbesserter fermentationsausbeute in hefe
US7378390B2 (en) 1999-12-29 2008-05-27 Novo Nordisk A/S Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast
EP1265630B1 (fr) 2000-03-24 2006-06-07 Genentech, Inc. Utilisation de l'insuline pour traiter des affections des cartilages
US6821755B2 (en) * 2000-07-27 2004-11-23 Boehringer Ingelheim International Gmbh Preparation of a recombinant protein in a prokaryotic host cell
AR025646A1 (es) 2000-09-13 2002-12-04 Beta Lab Sa Cepa de levaduras metilotroficas recombinantes productoras de un precursor de insulina, construcciones de adn y metodo para obtener la cepa.
KR100449454B1 (ko) * 2000-10-02 2004-09-21 이현철 단일사슬 인슐린 유도체의 유전자를 포함하는 당뇨병치료용 벡터
US7105314B2 (en) 2001-04-02 2006-09-12 Novo Nordisk A/S Method for making human insulin precursors
WO2002079251A2 (fr) * 2001-04-02 2002-10-10 Novo Nordisk A/S Methode de fabrication de precurseurs d'insuline humaine
ES2306981T3 (es) 2003-01-31 2008-11-16 N.V. Organon Metodo para aislamiento de proteinas en condiciones anoxicas.
MX2008000985A (es) 2005-07-21 2008-04-07 Abbott Lab Expresion de gen multiple que incluye construcciones y metodos sorf (cuadro de lectura abierta simple) con poliproteinas, pro-proteinas y proteolisis.
MX2008003362A (es) 2005-09-14 2008-03-25 Sanofi Aventis Deutschland Escision de precursores de insulinas mediante una variante de tripsina.
EP2404934A1 (fr) 2006-09-22 2012-01-11 Novo Nordisk A/S Analogues d'insuline résistants à la protéase
CN101173006B (zh) * 2006-10-30 2011-12-21 江苏万邦生化医药股份有限公司 一种重组人胰岛素的制备方法
US10100098B2 (en) 2006-12-13 2018-10-16 Stelis Biopharma Private Limited Insulin production methods and proinsulin constructs
US7790677B2 (en) 2006-12-13 2010-09-07 Elona Biotechnologies Insulin production methods and pro-insulin constructs
WO2009066320A2 (fr) 2007-09-21 2009-05-28 Cadila Healthcare Limited Systèmes de protéines de fusion appropriés pour une expression élevée de peptides
HUE027239T2 (en) 2009-06-26 2016-10-28 Novo Nordisk As Preparation containing insulin, nicotinamide and arginine
JP2013545782A (ja) 2010-12-14 2013-12-26 ノヴォ ノルディスク アー／エス 長時間作用型インスリンと組み合わせた速効型インスリン
MX2013006174A (es) 2010-12-14 2013-07-15 Novo Nordisk As Preparacion que comprende insulina, nicotinamida y un aminoacido.
EP2739646B1 (fr) 2011-05-10 2018-01-24 Stefan Hermann Système tampon complet pour la renaturation de la pro-insuline humaine ou de dérivés de pro-insuline humaine
WO2013186138A1 (fr) 2012-06-14 2013-12-19 Novo Nordisk A/S Préparation comprenant de l'insuline, du nicotinamide et de l'arginine
JP2016183118A (ja) * 2015-03-25 2016-10-20 東ソー株式会社 増殖因子前駆体のリフォールディング方法
US10745457B2 (en) 2015-09-02 2020-08-18 Merck Sharp & Dohme Corp. Process for obtaining insulin with correctly formed disulfide bonds
KR20190036956A (ko) 2017-09-28 2019-04-05 한미약품 주식회사 지속형 단쇄 인슐린 아날로그 및 이의 결합체
EP3845240A4 (fr) 2018-09-12 2021-11-03 Amphastar Nanjing Pharmaceuticals, Inc. Nouvelle structure de pro-insuline asparte et procédé de préparation d'insuline asparte
AU2020418205A1 (en) 2019-12-30 2022-08-04 Gan & Lee Pharmaceuticals Co., Ltd. Insulin derivative
CN114901680A (zh) 2019-12-30 2022-08-12 甘李药业股份有限公司 长效glp-1化合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI783365A (fi) * 1977-11-08 1979-05-09 Genentech Inc Foerfarande foer mikrobipolypeptiduttryck
US4411994A (en) * 1978-06-08 1983-10-25 The President And Fellows Of Harvard College Protein synthesis
FI792481A (fi) * 1978-08-11 1980-02-12 Univ California Syntes av enkaroytiskt protein genom anvaendning av mikro-organismer
GR70279B (fr) * 1979-09-12 1982-09-03 Univ California
DE3001928A1 (de) * 1980-01-19 1981-08-06 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enthaltenden mikroorganismus
CA1200773A (fr) * 1980-02-29 1986-02-18 William J. Rutter Liens d'expression

Also Published As

Publication number Publication date
JPS57163352A (en) 1982-10-07
GR78327B (fr) 1984-09-26
IL64634A (en) 1986-03-31
NZ199391A (en) 1985-12-13
PH20660A (en) 1987-03-23
DK582481A (da) 1982-08-13
IL64634A0 (en) 1982-03-31
ES508446A0 (es) 1984-01-01
KR830007828A (ko) 1983-11-07
ES8401777A1 (es) 1984-01-01
AU7914581A (en) 1982-07-08
ZA818953B (en) 1983-02-23
EP0055945A2 (fr) 1982-07-14
EP0055945A3 (fr) 1982-09-15

Similar Documents

Publication Publication Date Title
FI814172L (fi) Maennisko-proinsulin och daermed analoga foereningar och framstaellningsmetod genom mikrobiell polypeptid-expression och oeverfoering daerav i maennisko-insulin
FI822872L (fi) Acylfosfinoxidfoereningar och deras anvaendning
FI823486A0 (fi) Foerfarande foer bergbultning och bergbult
FI822375L (fi) Bromhexin-retardformer och foerfarande foer deras framstaellning
FI821627L (fi) Borrhammare avsedd foer borrning och slagborrning
FI821914A0 (fi) Foerfarande och belaeggningskomposition foer elektrofri doppningsbelaeggning
FI822979L (fi) Foerfarande foer foerbaettring av toleransen av roentgenkontrastmedel och genom foerfarandet erhaolkontrastmedel
FI821990A0 (fi) Pyrimidinderivater och foerfarande foer deras framstaellning
FI823446A0 (fi) Foerbaettrad komposition foer maskinell diskning och skoeljning
FI823088L (fi) Foerbaettringar i och angaoende tieno- och furopyridinium-substituerade kefalosporinderivat
FI822661A0 (fi) Foerbaettrad torkfiltvaev och torkfilt
FI822585L (fi) Kardiovaskulaersystem reglerande och antihypertensiva substituerade pyrrolidiner
FI821249A0 (fi) Polyamidfolier och deras framstaellningsfoerfarande
FI822566L (fi) Foerfarande och anordning foer fiberlindning
FI820215L (fi) Ihaoligt byggnadselement och byggnadselementsystem
FI813631A0 (fi) Foerstaerkt racketram och foerfarande foer framstaellning daerav
FI813206L (fi) Elektroniskt styrd frankeringsmaskin och fristaemplare
FI821547A0 (fi) Emaljeringsanordning och foerfarande foer tvao- eller flerskiktsemaljering i en braenning
FI822918L (fi) Transportband och framstaellningsfoerfarande
FI822341A0 (fi) Foerbaettringar i och foer benzoylfenylureaderivat
FI820380L (fi) Segmentslipsten och slipsegment
FI822833L (fi) Vingsegelfartyg och vingsegel foer detta
FI822978L (fi) Jodbrombensenfoereningar och dessa innehaollande roentgenkontrastmedel
FI822042A0 (fi) Belaeggnings- och foerhydningspanel speciellt foer byggnader och dylika
FI822925A0 (fi) Framstaellningsfoerfarande foer alkoxivinkaminsyraestrar och alkoxiapovinkaminsyra-estrar

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: GENENTECH, INC.